N-aryltetrahydroisoquinoline derivatives as HA-CD44 interaction inhibitors: Design, synthesis, computational studies, and antitumor effect

Artículo original

Año: 2023

Espejo-Román, JM; Rubio-Ruiz, B; Chayah-Ghaddab, M; Vega-Gutierrez, C; García-García, G; Muguruza-Montero, A; Domene, C; Sánchez-Martín, RM; Cruz-López, O; Conejo-García, A

Título: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

• Q1